KRT18 and metabolic dysfunction-associated steatotic liver disease: Moreover, the CK-18 concentration after the remission of NAFLD decreased to 84.7 U/L (53.3–135.8), thus reaching a range of values similar to that in the low CK-18 group in our study on the Polish population.